Abstract：Objective To investigate the safety of intraoperative electron radiation therapy (IOERT) for stage I hepatocellular carcinoma (HCC) by a cohort study. Methods From November 2010 to May 2012, 16 patients who were pathologically diagnosed with stage I HCC underwent IOERT after radical resection. With a cohort study, 87 patients with stage I HCC who underwent radical resection alone during the same period were qualified, and according to tumor size (>5 cm and ≤5 cm) and resection margin (close margin and negative margin), 32 of 87 patients made up the control group. The intraoperative and postoperative adverse events, liver function parameters, coagulogram, and routine blood parameters, as well as IOERT-related adverse reactions, were evaluated. Independent-samples t test was used for analyzing the differences between groups. Results Compared with the control group, the IOERT group had a significantly longer operative time ((275.4±71.55) min vs. (184.7±64.74) min, P=0.000), a slightly higher incidence of intraoperative adverse events (18.75% vs. 6.25%, P=1.000), a slightly lower incidence of operative complications (12.50% vs. 28.12%, P=0.460), and a lower perioperative mortality (0 vs. 6%, P=0.440). Liver function parameters showed no significant differences between the two groups (P>0.05). There were no significant differences between the two groups in postoperative time to grade 1 or normal liver function parameters, median length of postoperative hospital stay, length of hospital stay in the surgical department, time to incision healing, and level of incision healing (P>0.05). During follow-up, no radiation hepatitis was found in the IOERT group. Conclusions As an adjuvant therapy after radical resection for early HCC, IOERT has no significant side effects on postoperative recovery and liver function, and an intraoperative dose of 15-16 Gy is safe.
Xu Cai,Feng Qinfu,Bi Xinyu et al. Safety of intraoperative electron radiation therapy for primary hepatocellular carcinoma:a cohort study[J]. Chinese Journal of Radiation Oncology, 2014, 23(5): 386-389.
[1] Morris-Stiff G, Gomez D,de Liguori Carino N, et al. Surgical management of hepatocellular carcinoma:is the jury still out[J]? Surg Oncol,2009,18:298-321. [2] Hemming AW, Cattral MS, Reed AI, et al. Liver transplantation for hepatocellular carcinoma[J]. Ann Surg,2001,233:652-659. [3] Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma:comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria[J]. Liver Transpl,2002,8:765-774. [4] Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma[J]. Semin Liver Dis,2005,25:181-200. [5] Llovet JM, Fuster J, Bruix J. The Barcelona approach:diagnosis, staging, and treatment of hepatocellular carcinoma[J]. Liver Transpl,2004,10:115-120. [6] Shah SA, Cleary SP, Wei AC, et al. Recurrence after liver resection for hepatocellular carcinoma:risk factors, treatment, and outcomes[J]. Surgery,2007,141:330-339. [7] Mathurin P, Raynard B, Dharancy S, et al. Meta-analysis:evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma[J]. Aliment Pharmacol Ther,2003,17:1247-1261. [8] Scaife CL, Calvo FA, Noyes RD. Intraoperative radiotherapy in the multimodality approach to gastric cancer[J]. Surg Oncol Clin North Am,2003,12:955-964. [9] Ogata T, Araki K, Matsuura K, et al. A 10-year experience of intraoperative radiotherapy for gastric carcinoma and a new surgical method of creating a wider irradiation field for cases of total gastrectomy patients[J]. Int J Radiat Oncol Biol Phys,1995,32:341-347. [10] 王成锋,白晓枫,张建伟,等.术中放疗在局部晚期胰腺癌治疗中的作用[J].中华医学杂志,2011,91:243-246. [11] 翟医蕊,冯勤付,李明辉,等.腹部肿瘤术中电子线放疗安全性和急性副反应观察[J].中华放射肿瘤学杂志,2010,19:448-451. [12] Skoropad VY, Berdov BA, Mardynski YS, et al. A prospective, randomized trial of preoperative and intraoperative radiotherapy versus surgery alone in resectable gastric cancer[J]. Eur J Surg Oncol,2000,26:773-779. [13] Martinez-Monge R, Calvo FA, Azinovic I, et al. Patterns of failure and long-term results in high-risk resected gastric cancer treated with postoperative radiotherapy with orwithout intraoperative electron boost[J]. J Surg Oncol,1997,66:24-29. [14] Kramling HJ, Willich N, Cramer C, et al. Early results of IORT in the treatment of gastric cancer[J]. Front Radiat Ther Oncol,1997,31:157-160. [15] Drognitz O, Henne K, Weissenberger C, net al. Long-term results after intraoperative radiation therapy for gastric cancer[J]. Int J Radiat Oncol Biol Phys,2008,70:715-721.
2014, Vol. 23 
